Lupus

      Prelude to a Meeting (ACR22) (11.11.2022)
      2 years 11 months ago
      Convention2.jpg
      AS, Lupus and Subclinical RA: What I'm looking forward to at ACR22
      2 years 11 months ago
      As we approach ACR22, there are many things to be excited about, especially with the reintroduction of in-person attendance. My attention this year is in research being presented in these three areas: ankylosing spondylitis; lupus management and treatment; and, subclinical RA.
      Plaquenil (HCQ) reduces #SLE mortality. Metanalysis (21 studies, 26,037 pts). Pooled findings - HCQ significantly reduce

      Dr. John Cush RheumNow

      2 years 11 months ago
      Plaquenil (HCQ) reduces #SLE mortality. Metanalysis (21 studies, 26,037 pts). Pooled findings - HCQ significantly reduced SLE mortality (HR 0.46); HCQ also reduced mortality in SLE pts w/ renal (HR=0.43), & cardiopulmonary dz (HR=0.37) https://t.co/fsHaN8wR17 https://t.co/MW8cvavzBC
      Cluster analysis of 112 SLE pts looked at Erosive arthritis. Arthritis seen in 73%, arthralgia in 27%, erosive arthrit

      Dr. John Cush RheumNow

      2 years 11 months ago
      Cluster analysis of 112 SLE pts looked at Erosive arthritis. Arthritis seen in 73%, arthralgia in 27%, erosive arthritis in 26%. Cluster that included erosive Dz also seen w/ CNS EL, serositis, Pos tests for ACPA, Carp, Sm, RNP, Dkk1 https://t.co/c7SLmFtweu https://t.co/qt9FdA1SBa

      Podcasts

      • ACR2022 - Day 1.1 00:29:38

      Catch up on Conference Podcasts

      ×